美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Range Cancer Therapeutics ETF

9.02

0.0000

成交量：- -

成交额：- -

市值：704.29万

市盈率：23.74

高：9.02

开：9.02

低：9.02

收：9.02

52周最高：9.02

52周最低：9.02

股本：78.08万

流通股本：78.08万

量比：- -

换手率：- -

股息：0.00

股息率：0.01%

每股收益(TTM):0.3800

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):- -

数据加载中...

总览公司新闻资讯公告

光遗传学斩获2026年诺奖哪些药企有布局？进展如何？

英国研究推进阿尔茨海默病基因疗法开发

港股异动 | 君实生物(01877)涨超4% 与美杰医疗达成战略合作探索肿瘤治疗“多模态药械联用”

UniQure在美上市股票下跌40%，此前该公司亨廷顿病基因疗法在研究中未能显著延缓疾病进展。

UniQure在美上市股票盘前下跌68%，此前该公司披露其亨廷顿舞蹈症基因疗法的早期至中期研究未达预期。

辉瑞（PFE）拟于2026年ESMO大会公布45项研究数据推进下一代肿瘤治疗管线

基因疗法后期研发企业ADARx Pharmaceuticals Inc. 正式公布调高规模的首次公开募股定价，成功募得

最有希望治愈乙肝的基因疗法已进入人体试验：不切DNA就能关闭病毒“开关”

DeepTech深科技

美国食品药品监督管理局：批准首款用于治疗A型桑菲利波综合征儿科患者的基因疗法。

天价基因疗法药物中国降价140万元后，终于有患者用了

当“毛孩子”老去，5万肿瘤治疗清单催生宠物抗癌险

微博财经-财道工作室

富人比穷人平均多活14.6年！AI、基因疗法与癌症疫苗正如何重塑人类寿命天花板

富人比穷人平均多活14.6年！AI、基因疗法与癌症疫苗正如何重塑人类寿命天花板

诺华：出现死亡病例，暂停自身免疫细胞疗法相关研究

拜耳旗下AskBio完成2期心力衰竭基因疗法试验入组

中国首款血友病基因疗法被退货，天价药支付困局如何破解？

华夏时报网

REGENXBIO股价下跌24%，此前美国食品药品监督管理局暂停了该公司针对亨特综合征的基因疗法的临床试验。

【券商聚焦】中信建投：肿瘤mRNA疫苗开创肿瘤治疗新范式，国内企业加速追赶

中信建投：肿瘤mRNA疫苗开创肿瘤治疗新范式国内企业加速追赶

FDA授予Xellsmart帕金森病现货型细胞疗法快速通道资格

环球市场播报

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hans/stock/CNCR/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CNCR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNCR\",,,,,undefined,":{"symbol":"CNCR","market":"US","secType":"STK","nameCN":"Range Cancer Therapeutics ETF","latestPrice":9.02,"timestamp":1791835200000,"preClose":9.02,"halted":0,"volume":0,"delay":0,"changeRate":0,"floatShares":780814,"shares":780814,"eps":0.38,"marketStatus":"已收盘","change":0,"latestTime":"10-12 16:00:00 EDT","open":9.02,"high":9.02,"low":9.02,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0.38,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791878400000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":9.02,"sharesOutstanding":780814,"nav":8.9,"aum":6949244.6,"dividendRate":0.000111,"bidAskSpread":0,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CNCR\",,,,,undefined,":{"symbol":"CNCR","floatShares":780814,"roa":"--","roe":"--","lyrEps":0,"shares":780814,"dividePrice":0.001,"high":9.02,"amplitude":0,"preClose":9.02,"low":9.02,"week52Low":9.02,"pbRate":"--","week52High":9.02,"institutionHeld":0,"latestPrice":9.02,"eps":0.38,"divideRate":0.000111,"volume":0,"delay":0,"ttmEps":0.38,"open":9.02,"prevYearClose":9.02,"prevWeekClose":9.02,"prevMonthClose":9.02,"prevQuarterClose":9.02,"fiveDayClose":9.02,"twentyDayClose":9.02,"sixtyDayClose":9.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CNCR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-28","symbol":"CNCR","reason":null,"defaultRemindTime":1748439000000,"announcedDate":"2025-05-27","type":"delisting","dateTimestamp":1748404800000},{"market":"US","date":"2021-12-29","symbol":"CNCR","amount":1.8533352,"defaultRemindTime":1640788200000,"name":"Loncar Cancer Immunotherapy ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000},{"market":"US","date":"2020-12-30","symbol":"CNCR","amount":0.2881193,"name":"Loncar Cancer Immunotherapy ETF","recordDate":"2021-01-04","payableDate":"2020-12-31","currency":"USD","type":"dividend","dateTimestamp":1609304400000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CNCR\",market:\"US\",,,undefined,":[{"executeDate":"2020-12-30","recordDate":"2020-12-31","paymentDate":"2021-01-04","value":0.2881193,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":1.8533352,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CNCR\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CNCR\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673802030","title":"光遗传学斩获2026年诺奖 哪些药企有布局？进展如何？","url":"https://stock-news.laohu8.com/highlight/detail?id=2673802030","media":"澎湃新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673802030?lang=zh_cn&edition=fundamental","pubTime":"2026-10-06 08:46","pubTimestamp":1791247560,"startTime":"0","endTime":"0","summary":"【光遗传学斩获2026年诺奖 哪些药企有布局？进展如何？】当地时间10月5日，瑞典卡罗琳医学院宣布，将2026年诺贝尔生理学或医学奖授予美国科学家卡尔·戴塞罗思、德国科学家彼得·黑格曼和格奥尔格·内格尔，以表彰他们在光门控离子通道和光遗传学方面的发现。随着诺贝尔奖光环的加持，光遗传学这一赛道有望在医药行业引发新的热潮。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202610063888722240.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202610063888722240.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["CNCR","BK4139","BK4007","IRD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672727481","title":"英国研究推进阿尔茨海默病基因疗法开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2672727481","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672727481?lang=zh_cn&edition=fundamental","pubTime":"2026-10-04 16:07","pubTimestamp":1791101275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671224513","title":"港股异动 | 君实生物(01877)涨超4% 与美杰医疗达成战略合作 探索肿瘤治疗“多模态药械联用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2671224513","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671224513?lang=zh_cn&edition=fundamental","pubTime":"2026-09-30 10:42","pubTimestamp":1790736130,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物涨超4%，截至发稿，涨4.03%，报19.09港元，成交额2326.84万港元。消息面上，据君实生物官微消息，公司宣布与美杰医疗于近日正式签署战略合作协议，双方将围绕“多模态热物理免疫调控平台技术与药物联合临床研究、新药靶点探索”等核心方向展开全方位战略合作，引领肿瘤治疗迈向“多模态药械联用”的新时代。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1502490.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK4585","BK1515","LU0329678170.USD","CNCR","CANC","KCAI","BK4588","LU2488822045.USD","BK1209","159891","VXUS","LU0737861772.HKD","BK1161","LU0329678337.USD","06078","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671921710","title":"UniQure在美上市股票下跌40%，此前该公司亨廷顿病基因疗法在研究中未能显著延缓疾病进展。","url":"https://stock-news.laohu8.com/highlight/detail?id=2671921710","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671921710?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 21:32","pubTimestamp":1790688723,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671167972","title":"UniQure在美上市股票盘前下跌68%，此前该公司披露其亨廷顿舞蹈症基因疗法的早期至中期研究未达预期。","url":"https://stock-news.laohu8.com/highlight/detail?id=2671167972","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671167972?lang=zh_cn&edition=fundamental","pubTime":"2026-09-29 19:22","pubTimestamp":1790680978,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IPOS","CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670234718","title":"辉瑞（PFE）拟于2026年ESMO大会公布45项研究数据 推进下一代肿瘤治疗管线","url":"https://stock-news.laohu8.com/highlight/detail?id=2670234718","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670234718?lang=zh_cn&edition=fundamental","pubTime":"2026-09-28 19:51","pubTimestamp":1790596274,"startTime":"0","endTime":"0","summary":"金吾财讯 | 辉瑞公司 宣布，将在2026年10月23日至27日于西班牙马德里举行的欧洲肿瘤内科学会大会上展示45项研究摘要，涵盖11场口头报告。本次发布的数据重点聚焦乳腺癌、泌尿生殖系统肿瘤及肺癌领域，旨在强化已上市药物的循证依据，同时展示后期管线中的突破性进展。3）Tivunatamig：展示联合化疗治疗一线PD-L1表达NSCLC的2期更新数据，并计划开展与PADCEV联合治疗转移性尿路上皮癌的3期试验。","market":"other","thumbnail":"https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250107/YjU2YzAxODc0YzFlOTM1Nzk3MTU1NDIzZDRjODY4MTE1MzM5MTg2.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"306551","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002224.SGD","IE00B19Z3B42.SGD","LU0329678170.USD","CNCR","LU0306806265.USD","BK1583","IE00B19Z3581.USD","IE00BLSP4239.USD","LU1894683348.USD","LU0170899867.USD","LU2488822045.USD","BK4588","IE000M9KFDE8.USD","IE00BLSP4452.SGD","LU0737861772.HKD","IE0002270589.USD","BK4585","SG9999001176.SGD","LU0058720904.USD","LU0306807586.USD","06078","LU0985481810.HKD","SGXZ57979304.SGD","LU0321505439.SGD","BK4581","BK4599","LU0456855351.SGD","LU0225771236.USD","LU0321505868.SGD","IE00B3T34201.USD","LU0868494617.USD","BK4007","BK4592","LU1023059063.AUD","IE00BBT3K403.USD","LU0234572021.USD","BK4550","LU0289739699.SGD","SG9999002232.USD","LU1066053197.SGD","LU1057294990.SGD","SG9999001176.USD","BK4533","BK4568","OZEM","LU1066051498.USD","LU0225284248.USD","CANC","BK1209","PFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670162224","title":"基因疗法后期研发企业ADARx Pharmaceuticals Inc. 正式公布调高规模的首次公开募股定价，成功募得","url":"https://stock-news.laohu8.com/highlight/detail?id=2670162224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670162224?lang=zh_cn&edition=fundamental","pubTime":"2026-09-25 07:50","pubTimestamp":1790293846,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR","LQPE","QQQS","SPCK","IPO","PEVC","ACSG","BCSM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669141667","title":"最有希望治愈乙肝的基因疗法已进入人体试验：不切DNA就能关闭病毒“开关”","url":"https://stock-news.laohu8.com/highlight/detail?id=2669141667","media":"DeepTech深科技","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669141667?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 19:28","pubTimestamp":1790076480,"startTime":"0","endTime":"0","summary":"乙肝是种顽固且极难被消灭的病毒。截至 2025 年，全球的慢性乙肝病毒感染者多达 2.5 亿人。gRNA 负责锁定乙肝病毒基因组一处高度保守的位点，让整套系统精准定位在病毒 DNA 上而不误伤人类基因。药物主要送入了肝脏和脾脏，睾丸和卵巢的生殖细胞中均未检出相关成分。结果显示，没有任何人类基因同时出现异常甲基化和相关表达变化。不过，考虑到任何非人灵长类动物都无法自然感染乙肝病毒，目前尚不明确该疗法在患者体内的转化效率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-22/doc-inistewv6773702.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668720991","title":"美国食品药品监督管理局：批准首款用于治疗A型桑菲利波综合征儿科患者的基因疗法。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668720991","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668720991?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 02:36","pubTimestamp":1789670163,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666533800","title":"天价基因疗法药物中国降价140万元后，终于有患者用了","url":"https://stock-news.laohu8.com/highlight/detail?id=2666533800","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666533800?lang=zh_cn&edition=fundamental","pubTime":"2026-09-09 20:27","pubTimestamp":1788956872,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665432080","title":"当“毛孩子”老去，5万肿瘤治疗清单催生宠物抗癌险","url":"https://stock-news.laohu8.com/highlight/detail?id=2665432080","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665432080?lang=zh_cn&edition=fundamental","pubTime":"2026-09-08 18:48","pubTimestamp":1788864480,"startTime":"0","endTime":"0","summary":"“这激发我们着手研发国内首款萌宠抗癌保险。”宠物抗癌险背后的经济账此前，赵先生给旺财投保了一份宠物险，但是单次赔偿限额仅有1500元。李爽说，肿瘤、肾病等老年高发疾病的诊疗负担，正成为养宠家庭绕不开的问题。保险公司需要进行广泛的数据分析与精算，以确定不同类型犬猫高发肿瘤诊疗理赔范畴，并确保整体理赔风险可控。李爽坦言，众安保险正计划以宠物肿瘤诊断为支点，持续完善覆盖宠物全生命周期的保障体系。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-09-08/doc-inircmeu9366925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1209","06078","CNCR","CANC","LU0329678170.USD","LU0329678337.USD","BK1583","LU0737861772.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664884623","title":"富人比穷人平均多活14.6年！AI、基因疗法与癌症疫苗正如何重塑人类寿命天花板","url":"https://stock-news.laohu8.com/highlight/detail?id=2664884623","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664884623?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 09:13","pubTimestamp":1788484392,"startTime":"0","endTime":"0","summary":"9月4日，在人类漫长的发展历程里，活到100岁，已经是人们对于生命长度最美好的想象。财富与寿命之间的差距早已存在。2016年，Raj Chetty等学者在《美国医学会杂志》发表了一项研究。他们整合了14亿条去身份化纳税记录以及美国社会保障管理局的死亡记录，估算不同收入人群在40岁时的预期寿命。结果发现，收入最高1%的男性，预期死亡年龄为87.3岁；收入最低1%的男性，只有72.7岁，相差14.6年。女性分别为88.9岁和78.8岁，相差10.1年。","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/09/04091358345285.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["CNCR","VTHR","ARTY","159646","AIPO","QTOC","CHAT","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664388810","title":"富人比穷人平均多活14.6年！AI、基因疗法与癌症疫苗正如何重塑人类寿命天花板","url":"https://stock-news.laohu8.com/highlight/detail?id=2664388810","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664388810?lang=zh_cn&edition=fundamental","pubTime":"2026-09-04 09:07","pubTimestamp":1788484045,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["AIPO","CHAT","QTOC","CNCR","ARTY","159646","VTHR","AGIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664800188","title":"诺华：出现死亡病例，暂停自身免疫细胞疗法相关研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2664800188","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664800188?lang=zh_cn&edition=fundamental","pubTime":"2026-09-01 12:21","pubTimestamp":1788236460,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4532","BK4578","LU0211331839.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD","BK4007","LU0208291251.USD","NVS","IE00B4R5TH58.HKD","IE0009355771.USD","CNCR","IE00BFTCPJ56.SGD","SYNB","PPH","IE00B2B36J28.USD","BK4585","MEDX","IE0002141913.USD","LU0070302665.USD","BK4588","IE00BJT1NW94.SGD","WDNA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663267320","title":"拜耳旗下AskBio完成2期心力衰竭基因疗法试验入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2663267320","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663267320?lang=zh_cn&edition=fundamental","pubTime":"2026-08-31 10:28","pubTimestamp":1788143322,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663012684","title":"中国首款血友病基因疗法被退货，天价药支付困局如何破解？","url":"https://stock-news.laohu8.com/highlight/detail?id=2663012684","media":"华夏时报网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663012684?lang=zh_cn&edition=fundamental","pubTime":"2026-08-29 15:25","pubTimestamp":1787988312,"startTime":"0","endTime":"0","summary":"武田与信念医药终止三年合作，上市逾一年仍未开出首张处方。近日，武田中国与信念医药发布联合声明，宣布双方关于血友病B基因疗法波哌达可基注射液（商品名：信玖凝?）的商业化合作已于8月2日正式终止。这意味着，这桩缔结于2023年10月的独家商业化合作，在存续不足三年后宣告终结。据悉，波哌达可基是中国首个获批上市的血友病B基因治疗药物，也是全国首款获批的基因治疗产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608293859274280.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608293859274280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["CNCR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271420","title":"REGENXBIO股价下跌24%，此前美国食品药品监督管理局暂停了该公司针对亨特综合征的基因疗法的临床试验。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271420","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271420?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 21:32","pubTimestamp":1787578348,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR","BMED","PSYK","IBBJ","MDTX","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661244441","title":"【券商聚焦】中信建投：肿瘤mRNA疫苗开创肿瘤治疗新范式，国内企业加速追赶","url":"https://stock-news.laohu8.com/highlight/detail?id=2661244441","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661244441?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 09:19","pubTimestamp":1787534349,"startTime":"0","endTime":"0","summary":"金吾财讯 | 中信建投证券研究指，随着Moderna个性化肿瘤mRNA疫苗临床III期取得积极结果，mRNA肿瘤疫苗正朝着商业化阶段迈进，市场空间有望逐步打开。mRNA肿瘤疫苗与ICIs联用有望开创肿瘤治疗的新范式。分类来看，个性化肿瘤疫苗具有潜在更优的治疗效果，虽然生产成本较高，但也有更大的定价空间，而通用型疫苗凭规模化生产和较低成本，有望覆盖更广泛的患者群体。AI有望赋能多个环节，加速mRNA肿瘤疫苗的迭代升级。目前国内肿瘤mRNA疫苗研发正加速追赶，未来有望实现差异化突破，相关企业及产业链公司有望受益。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MWQ0NzJkZTcxMzM4ODY4MjA2MzM0OTUz.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1989097","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KCE","LU0737861772.HKD","CNCR","CANC","BK1583","601066","MRNX","MRNY","BK0276","LU0329678170.USD","06078","BK1209","LU2488822045.USD","LU0329678337.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661991241","title":"中信建投：肿瘤mRNA疫苗开创肿瘤治疗新范式 国内企业加速追赶","url":"https://stock-news.laohu8.com/highlight/detail?id=2661991241","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661991241?lang=zh_cn&edition=fundamental","pubTime":"2026-08-24 08:26","pubTimestamp":1787531164,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["CNCR","MRNY","MRNX","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656875551","title":"FDA授予Xellsmart帕金森病现货型细胞疗法快速通道资格","url":"https://stock-news.laohu8.com/highlight/detail?id=2656875551","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656875551?lang=zh_cn&edition=fundamental","pubTime":"2026-08-04 21:07","pubTimestamp":1785848846,"startTime":"0","endTime":"0","summary":"XellSmart专有的现货型iPSC衍生细胞疗法XS411获得美国FDA快速通道资格，标志着其全球临床开发的重要里程碑。　　2026年7月28日，XellSmart宣布，其自主研发的针对帕金森病的同种异体、现货型、可注射iPSC衍生细胞疗法候选产品XS411，已正式获得美国食品药品监督管理局授予的快速通道资格。这一监管认定彰显了美国卫生监管机构对XS411临床价值及其解决帕金森病治疗中重大未满足临床需求潜力的认可，是其全球临床开发和未来市场准入的关键里程碑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-08-04/doc-inimeknz5555117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["BK4588","SYNB","BK4585","WDNA","CNCR","LABU"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":24,"code":"91000000","status":"200"}]}}